{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:22:54Z","timestamp":1791238974964,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["bprclinrheum.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.berh.2013.07.008","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T02:16:13Z","timestamp":1384481773000},"page":"391-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":269,"title":["Cutaneous lupus erythematosus: Diagnosis and\u00a0treatment"],"prefix":"10.1016","volume":"27","author":[{"given":"L.G.","family":"Okon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.P.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2013.07.008_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/096120339700600204","article-title":"Epidemiology and socioeconomic impact of skin disease in lupus erythematosus","volume":"6","author":"Tebbe","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2013.07.008_bib2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2012.08.019","article-title":"Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)","volume":"12","author":"Biazar","year":"2013","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.berh.2013.07.008_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1191\/0961203304lu2020oa","article-title":"Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus","volume":"13","author":"Albrecht","year":"2004","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.berh.2013.07.008_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gronhagen","year":"2011","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib5","first-page":"S45","article-title":"Progression from cutaneous to systemic lupus erythematosus by ACR criteria usually occurs with mild disease and few systemic symptoms","volume":"132","author":"Wieczorek","year":"2012","journal-title":"Journal of Investigative Dermatology (Abstract)"},{"issue":"8","key":"10.1016\/j.berh.2013.07.008_bib6","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2013.07.008_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","article-title":"Distinctive cutaneous subsets in the spectrum of lupus erythematosus","volume":"4","author":"Gilliam","year":"1981","journal-title":"Journal of American Academy of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib8","series-title":"Cutaneous lupus erythematosus","first-page":"53","article-title":"Classification of cutaneous lupus erythematosus","author":"Kuhn","year":"2004"},{"key":"10.1016\/j.berh.2013.07.008_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1440-0960.2000.00443.x","article-title":"Epidemiology of cutaneous lupus erythematosus in a tertiary referral centre in Singapore","volume":"41","author":"Ng","year":"2000","journal-title":"Australian Journal of Dermatology"},{"issue":"7","key":"10.1016\/j.berh.2013.07.008_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00128071-200304070-00002","article-title":"Cutaneous lupus erythematosus: diagnosis and management","volume":"4","author":"Fabbri","year":"2003","journal-title":"American Journal of Clinical Dermatology"},{"issue":"6","key":"10.1016\/j.berh.2013.07.008_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11310780-000000000-00000","article-title":"Cutaneous lupus erythematosus: issues in diagnosis and treatment","volume":"10","author":"Walling","year":"2009","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib12","series-title":"Dermatology","first-page":"601","article-title":"Lupus erythematosus","author":"Lee","year":"2012"},{"key":"10.1016\/j.berh.2013.07.008_bib13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clindermatol.2006.07.014","article-title":"Lupus erythematosus: systemic and cutaneous manifestations","volume":"24","author":"Rothfield","year":"2006","journal-title":"Clinics in Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib14","first-page":"3","article-title":"Cutaneous lupus erythematosus: a review","volume":"20","author":"Patel","year":"2002","journal-title":"Clinics in Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archderm.1963.01590200064012","article-title":"Lupus erythematosus and erythema multiforme-like lesions","volume":"88","author":"Rowell","year":"1963","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1016\/j.berh.2013.07.008_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/0001555577305308","article-title":"Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients","volume":"77","author":"Tebbe","year":"1997","journal-title":"Acta Dermato Venereologica"},{"key":"10.1016\/j.berh.2013.07.008_bib17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780310811","article-title":"Subacute cutaneous lupus erythematosus: clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients","volume":"31","author":"Callen","year":"1988","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2013.07.008_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000018307","article-title":"Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus: a review by the Italian group of immunodermatology","volume":"200","author":"Parodi","year":"2000","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.berh.2013.07.008_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archdermatol.2008.594","article-title":"Cross-sectional analysis of a collaborative web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients","volume":"145","author":"Moghadam-Kia","year":"2009","journal-title":"Archives of Dermatology"},{"issue":"12","key":"10.1016\/j.berh.2013.07.008_bib20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.1979.04010120007006","article-title":"Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset","volume":"115","author":"Sontheimer","year":"1979","journal-title":"Archives of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-4362.2001.01067-5.x","article-title":"Subacute cutaneous lupus erythematosus with pityriasis-like cutaneous manifestations","volume":"40","author":"Caproni","year":"2001","journal-title":"International Journal of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib22","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1610-0387.2007.06554.x","article-title":"Clinical manifestations of cutaneous lupus erythematosus","volume":"5","author":"Kuhn","year":"2007","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"10.1016\/j.berh.2013.07.008_bib23","first-page":"1665","article-title":"Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus","volume":"21","author":"Cohen","year":"1994","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2013.07.008_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0738-081X(85)90078-1","article-title":"Subacute cutaneous lupus erythematosus","volume":"3","author":"Sontheimer","year":"1985","journal-title":"Clinics in Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-97-5-664","article-title":"Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus","volume":"97","author":"Sontheimer","year":"1982","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.berh.2013.07.008_bib26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden","volume":"167","author":"Gronhagen","year":"2012","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2133.1988.tb02580.x","article-title":"Dust-like particles: a specific direct immunofluorescence pattern in sub-acute cutaneous lupus erythematosus","volume":"118","author":"Nieboer","year":"1988","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0560.2001.280101.x","article-title":"The cutaneous pathology of lupus erythematosus: a review","volume":"28","author":"Crowson","year":"2001","journal-title":"Journal of Cutaneous Pathology"},{"issue":"1","key":"10.1016\/j.berh.2013.07.008_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2133.2011.10610.x","article-title":"Determining risk factors for developing systemic lupus erythematosus in patients with DLE","volume":"166","author":"Chong","year":"2012","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.2009.09472.x","article-title":"Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients","volume":"162","author":"Vera-Recabarren","year":"2010","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib31","first-page":"156","article-title":"Squamous cell carcinoma of the skin in black patients with discoid lupus erythematosus","volume":"14","author":"Caruso","year":"1987","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2013.07.008_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/sder.2001.23091","article-title":"Cutaneous lupus erythematosus","volume":"20","author":"McCauliffe","year":"2001","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"key":"10.1016\/j.berh.2013.07.008_bib33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00000372-199710000-00003","article-title":"Atypical lymphoid infiltrates arising in cutaneous lesions of connective tissue disease","volume":"19","author":"Magro","year":"1997","journal-title":"American Journal of Dermatopathology"},{"issue":"8","key":"10.1016\/j.berh.2013.07.008_bib34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10067-008-0942-9","article-title":"Chilblain lupus erythematosus: a review of the literature","volume":"27","author":"Hedrich","year":"2008","journal-title":"Clinics in Rheumatology"},{"key":"10.1016\/j.berh.2013.07.008_bib35","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.136.8.1033","article-title":"Lupus erythematosus tumidus: a neglected subset of cutaneous lupus erythematosus: report of 40 cases","volume":"136","author":"Kuhn","year":"2000","journal-title":"Archives of Dermatology"},{"issue":"7","key":"10.1016\/j.berh.2013.07.008_bib36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.1780310701","article-title":"Measurement of systemic lupus erythematosus activity in clinical research","volume":"31","author":"Liang","year":"1988","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2013.07.008_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2133.2000.03356.x","article-title":"Measuring the activity of the disease in patients with cutaneous lupus erythematosus","volume":"142","author":"Parodi","year":"2000","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","article-title":"The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus","volume":"125","author":"Albrecht","year":"2005","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"10.1016\/j.berh.2013.07.008_bib39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/art.23319","article-title":"The cutaneous lupus erythematosus disease activity and severity index: expansion for rheumatology and dermatology","volume":"59","author":"Krathen","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2013.07.008_bib40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jaad.2012.08.035","article-title":"Validation of the cutaneous lupus disease area and severity index (CLASI) using physician- and patient-assessed health outcome measures","volume":"68","author":"Jolly","year":"2012","journal-title":"Journal of American Academy of Dermatology"},{"issue":"1","key":"10.1016\/j.berh.2013.07.008_bib41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/2013.jamadermatol.467","article-title":"Quality of life differences between responders and non-responders in the treatment of cutaneous lupus erythematosus","volume":"149","author":"Chang","year":"2013","journal-title":"JAMA Dermatology"},{"issue":"2","key":"10.1016\/j.berh.2013.07.008_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archdermatol.2010.435","article-title":"Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus","volume":"147","author":"Klein","year":"2011","journal-title":"Archives of Dermatology"},{"issue":"5","key":"10.1016\/j.berh.2013.07.008_bib43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2133.2012.10825.x","article-title":"The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score","volume":"166","author":"Braunstein","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1016\/j.berh.2013.07.008_bib44","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/ar3549","article-title":"Tumor necrosis factor \u03b1 release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients","volume":"14","author":"Nabatian","year":"2012","journal-title":"Arthritis Research and Therapy"},{"key":"10.1016\/j.berh.2013.07.008_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2133.2012.11106.x","article-title":"A multi-center, cross-sectional study on quality of life in cutaneous lupus erythematosus","volume":"168","author":"Vasquez","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"70","key":"10.1016\/j.berh.2013.07.008_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/RHU.0b013e3181bb971b","article-title":"Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases","volume":"15","author":"Marin","year":"2009","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.berh.2013.07.008_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/1523-1747.ep12616582","article-title":"Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus","volume":"99","author":"David-Bajar","year":"1992","journal-title":"Journal of Investigative Dermatology"},{"issue":"8","key":"10.1016\/j.berh.2013.07.008_bib48","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/jid.2011.101","article-title":"Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol","volume":"131","author":"Kuhn","year":"2011","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"10.1016\/j.berh.2013.07.008_bib49","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/acr.21867","article-title":"Updated analysis of standardized photoprovocation in patients with cutaneous lupus erythematosus","volume":"65","author":"Ruland","year":"2013","journal-title":"Arthritis Care and Research"},{"issue":"1","key":"10.1016\/j.berh.2013.07.008_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1067\/mjd.2001.114589","article-title":"Phototesting in lupus erythematosus: a 15-year experience","volume":"45","author":"Kuhn","year":"2001","journal-title":"Journal of American Academy of Dermatology"},{"issue":"1","key":"10.1016\/j.berh.2013.07.008_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2009.12.053","article-title":"Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study","volume":"64","author":"Kuhn","year":"2011","journal-title":"Journal of American Academy of Dermatology"},{"issue":"4","key":"10.1016\/j.berh.2013.07.008_bib52","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1751-1097.2009.00540.x","article-title":"Analysis of compact fluorescent lights for use by patients with photosensitive conditions","volume":"85","author":"Klein","year":"2009","journal-title":"Photochemistry and Photobiology"},{"issue":"4","key":"10.1016\/j.berh.2013.07.008_bib53","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1751-1097.2009.00540.x","article-title":"Dermatological risk of indoor Ultraviolet exposure from compact fluorescent light or use by patients with photosensitive conditions","volume":"85","author":"Sayre","year":"2009","journal-title":"Photochemistry and Photobiology"},{"issue":"6","key":"10.1016\/j.berh.2013.07.008_bib54","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2010.06.018","article-title":"Cutaneous lupus erythematosus: update of therapeutic options: part 1","volume":"65","author":"Kuhn","year":"2011","journal-title":"Journal of American Academy of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib55","first-page":"CD002954","article-title":"Drugs for discoid lupus erythematosus","volume":"4","author":"Jessop","year":"2009","journal-title":"Cochrane Database System Review"},{"key":"10.1016\/j.berh.2013.07.008_bib56","first-page":"281","article-title":"Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy","volume":"25","author":"Roenigk","year":"1980","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.berh.2013.07.008_bib57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11926-011-0180-z","article-title":"Treatment of cutaneous lupus","volume":"13","author":"Chang","year":"2011","journal-title":"Current Rheumatology Reports"},{"issue":"1","key":"10.1016\/j.berh.2013.07.008_bib58","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2006.07595.x","article-title":"Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study","volume":"156","author":"Tzung","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1016\/j.berh.2013.07.008_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2010.03.037","article-title":"Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial","volume":"65","author":"Kuhn","year":"2011","journal-title":"American Academy of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clindermatol.2009.04.001","article-title":"Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies","volume":"28","author":"Thaci","year":"2010","journal-title":"Clinics in Dermatology"},{"issue":"6","key":"10.1016\/j.berh.2013.07.008_bib61","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1365-2133.2009.09330.x","article-title":"A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosus","volume":"161","author":"Jemec","year":"2009","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1016\/j.berh.2013.07.008_bib62","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaad.2008.11.904","article-title":"Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus","volume":"60","author":"Erceg","year":"2009","journal-title":"Journal of American Academy of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.1992.tb14851.x","article-title":"Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine","volume":"127","author":"Ruzicka","year":"1992","journal-title":"British Journal of Dermatology"},{"issue":"10","key":"10.1016\/j.berh.2013.07.008_bib64","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/art.21358","article-title":"Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus","volume":"52","author":"Bezerra","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"11","key":"10.1016\/j.berh.2013.07.008_bib65","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archdermatol.2011.191","article-title":"Response to antimalarials in cutaneous lupus erythematosus: a prospective analysis","volume":"147","author":"Chang","year":"2011","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1016\/j.berh.2013.07.008_bib66","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archdermatol.2011.2558","article-title":"Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study","volume":"148","author":"Frances","year":"2012","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1016\/j.berh.2013.07.008_bib67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archdermatol.2011.342","article-title":"Impact of smoking in cutaneous lupus erythematosus","volume":"148","author":"Piette","year":"2012","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1016\/j.berh.2013.07.008_bib68","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2230.2011.04266.x","article-title":"Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus","volume":"37","author":"Ezra","year":"2012","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib69","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"Recommendations on screening for chloroquine and\u00a0hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.berh.2013.07.008_bib70","first-page":"27","article-title":"Treatment of cutaneous lupus erythematosus: review and assessment of treatment benefits based on Oxford centre for evidence-based medicine criteria","volume":"6","author":"Winkelmann","year":"2013","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"issue":"6","key":"10.1016\/j.berh.2013.07.008_bib71","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.jaad.2010.06.017","article-title":"Cutaneous lupus erythematosus: update of therapeutic options: part 2","volume":"65","author":"Kuhn","year":"2011","journal-title":"Journal of American Academy of Dermatology"},{"issue":"1","key":"10.1016\/j.berh.2013.07.008_bib72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2133.2005.06552.x","article-title":"Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients","volume":"153","author":"Wenzel","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1016\/j.berh.2013.07.008_bib73","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2133.2007.07826.x","article-title":"Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy","volume":"156","author":"Kreuter","year":"2007","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib74","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(88)70259-5","article-title":"Resistant discoid lupus erythematosus of palms and soles: successful treatment with azathioprine","volume":"19","author":"Ashinoff","year":"1988","journal-title":"Journal of American Academy of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib75","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archderm.1985.01660100103026","article-title":"Successful treatment of generalized discoid skin lesions with azathioprine: its use in a patient with systemic lupus erythematosus","volume":"121","author":"Tsokos","year":"1986","journal-title":"Archives of Dermatology"},{"key":"10.1016\/j.berh.2013.07.008_bib76","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archderm.1986.01660160026007","article-title":"Successful treatment of generalized discoid skin lesions with azathioprine","volume":"122","author":"Shehade","year":"1986","journal-title":"Archives of Dermatology"},{"issue":"11","key":"10.1016\/j.berh.2013.07.008_bib77","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1136\/annrheumdis-2011-200831","article-title":"Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials","volume":"71","author":"Manzi","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1016\/j.berh.2013.07.008_bib78","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2133.2011.10693.x","article-title":"Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome","volume":"166","author":"Cortes-Hernandez","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1016\/j.berh.2013.07.008_bib79","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1523-1747.2002.19502.x","article-title":"Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients","volume":"119","author":"Bastuji-Garin","year":"2002","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"10.1016\/j.berh.2013.07.008_bib80","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaad.2011.01.015","article-title":"Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: histologic and circulating leukocyte profile and potential risk of a systemic lupus flare","volume":"66","author":"Braunstein","year":"2012","journal-title":"Journal of American Academy of Dermatology"},{"issue":"6","key":"10.1016\/j.berh.2013.07.008_bib81","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1186\/ar4111","article-title":"Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus","volume":"14","author":"Cort\u00e9s-Hern\u00e1ndez","year":"2012","journal-title":"Arthritis Research and Therapy"},{"issue":"3","key":"10.1016\/j.berh.2013.07.008_bib82","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archdermatol.2009.30","article-title":"Lenalidomide for the treatment of resistant discoid lupus erythematosus","volume":"145","author":"Shah","year":"2009","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1016\/j.berh.2013.07.008_bib83","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.jaad.2011.10.030","article-title":"Alitretinoin for cutaneous lupus erythematosus","volume":"67","author":"Kuhn","year":"2012","journal-title":"Journal of American Academy of Dermatology"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T10:52:11Z","timestamp":1688640731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694213000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1521694213000600"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2013.07.008","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous lupus erythematosus: Diagnosis and\u00a0treatment","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2013.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}